Prasanna Jagannathan MD
Assistant Professor, Medicine, University of California, San Francisco, School of
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Jagannathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2009 - 2011- University of California (San Francisco)Residency, Internal Medicine, 2005 - 2009
Harvard Medical SchoolClass of 2005
Certifications & Licensure
CA State Medical License 2007 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Regulatory KIRCD8T cells are elevated during human pregnancy.Jing Li, Xuerui Wang, Andreas I Lackner, Purnima Narasimhan, Lin Li
Science Translational Medicine. 2025-08-06 - Digital Biometric Measures in Long COVID: A Secondary Analysis of the STOP-PASC Randomized Clinical Trial.Fatma Gunturkun, Haley Hedlin, Bren Botzheim, Yaowei Deng, Hector Bonilla
JAMA Network Open. 2025-08-01 - Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual parti...Michelle E Roh, Julie R Gutman, Maxwell Murphy, Jenny Hill, Mywayiwawo Madanitsa
Eclinicalmedicine. 2025-05-01
Journal Articles
- Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of Malaria During Pregnancy and Risk of Malaria in Early Childhood: A Randomized Controlled TrialBryan Greenhouse, Prasanna Jagannathan, Diane V Havlir, PLoS One
Press Mentions
Women Are at Much Higher Risk of Long COVID Than Men. Why?March 25th, 2025- I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?September 5th, 2022
- Paxlovid for COVID-19: Important InformationJuly 14th, 2022
- Join now to see all
Grant Support
- Innate-adaptive immune bridging in gravidity-dependent immunity against placental malaria: a multi-omics approachSTANFORD UNIVERSITY2025–2030
- Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
- Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
- Deciphering mechanisms of CD4+ T cell-dependent clinical immunity to repeated Plasmodium infectionsSTANFORD UNIVERSITY2024–2029
- Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
- Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
- Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
- Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2025–2026
- Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
- Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
- Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
- Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
- Enhancing immunity to malaria in young children with effective chemopreventionSTANFORD UNIVERSITY2021–2026
- Computational models of naturally acquired immunity to falciparum malariaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
